Time is running out for CPHI Worldwide 2024, the world's leading platform for the pharmaceutical supply chain. The event, taking place this year in Milan from 8 to 10 October, will bring together industry leaders, professionals and companies for three days dedicated to networking and new exciting collaborations.
Biofarma Group will be among more than two thousand exhibiting companies presenting a portfolio of products reflecting the major trends and opportunities in the nutraceutical sector.
The number one most sought-after claim in the market is gut health, a trend driven largely by the growing demand for products designed to improve digestive function. Market data also show a growing interest in supplements that promote mental wellbeing in all its aspects: from concentration to relaxation and mood management. Women's health then represents a niche target that shows, however, an interesting positive growth trend, with a particular development for the area of products dedicated to combating the symptoms and effects of the menopause. Not only wellness but also beauty: in recent years, the sector has recorded a growing interest in products with a beauty target and, in particular, in products able to promote healthy skin by acting from within.
That's why Biofarma's innovations will focus on four main therapeutic focuses: Gut Health, Mental Health, Woman Health and Skin Health.
The stand will also offer an overview of the Group's technological capabilities, which range from solid and powder formulations to liquid formulations for both topical and oral use. This is achieved thanks to its 8 production plants spanning Europe, America and Asia and boasting cutting-edge technological and production skills, allowing for a customised offer based on specific customer needs.
A focus will also be dedicated to Innovation projects: these are highly innovative products, whose effects on specific therapeutic targets are supported by studies carried out in collaboration with recognised key opinion leaders, universities and major research centres. These include cancer immunotherapy, a project that has seen Biofarma Group involved in the development of a nutraceutical solution capable of supporting cancer patients, as an adjuvant treatment to immunotherapy.
To learn more about this and other projects and discover all Biofarma Group's main innovations in the Health Care field, visit stand 7C122 in hall 7: the Group's commercial team will be ready to meet you and start exciting new collaborations.
